SCHEMBL1952035

SCHEMBL1952035

Oc1nc(S)nc2n[nH]cc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxypurinol SCHEMBL2077651 0.83 — —
SCHEMBL15397499 0.72 MAPK1 (0.32) —
SCHEMBL95393 0.68 — —
Allopurinol SCHEMBL167561 0.67 CCNE2 (0.31) —
SCHEMBL1952036 0.64 SMN1; SMN2 (0.36) —
SCHEMBL162535 0.62 ADORA3 (0.36) —
SCHEMBL5880789 0.60 DYRK1A (0.38) —
SCHEMBL1724116 0.60 GDA (0.41) —
Tisopurine SCHEMBL7160585 0.58 — —
SCHEMBL11326338 0.58 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11851435-B2 PTGR2 inhibitors and their use NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-12-26 — — US disclosed
US-20230279008-A1 PTGR2 INHIBITORS AND THEIR USE NATIONAL TAIWAN UNIVERSITY (TW) 2023-09-07 — — US disclosed
EP-2271630-B1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS NOVARTIS AG (CH) 2016-03-23 — — EP disclosed
US-8592432-B2 Compounds and compositions as protein kinase inhibitors NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2013-11-26 — — US disclosed
US-20110135668-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2011-06-09 — — US disclosed
WO-2009126515-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-10-15 — — WO disclosed
US-RE38416-E1 NUCLEOTIDE BASES COMPRISING PYRAZOLO(3,4-D)PYRIMIDINES USED FOR MEDICAL DIAGNOSIS, THERAPY, HYBRIDIZATION, ANTISENSE AGENTS OR REPORTER MOLECULES EPOCH BIOSCIENCES, INC. 2004-02-03 — — US disclosed
EP-0881875-A4 COMPOSITIONS AND METHODS FOR CONTROLLING PEST INSECTS VIRGINIA TECH INTELL PROP (US) 2002-03-06 — — EP disclosed
US-6037344-A COMPRISING A PURINE SELECTED FROM THE GROUP CONSISTING OF XANTHINE, HYPOXANTHINE, GUANINE AND MIXTURES THEREOF, AND A XANTHINE OXIDASE INHIBITOR SELECTED FROM THE GROUP CONSISTING OF ALLOPURINOL, OXYPURINOL, MERCAPTO-ALLOPURINOL, VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2000-03-14 — — US disclosed
US-5990115-A Compositions and methods for controlling pest insects VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1999-11-23 — — US disclosed
EP-0881875-A1 COMPOSITIONS AND METHODS FOR CONTROLLING PEST INSECTS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1998-12-09 — — EP disclosed
EP-0842186-A1 CROSS-LINKING OLIGONUCLEOTIDES MICROPROBE CORPORATION (US) 1998-05-20 — — EP disclosed
WO-1997028686-A1 COMPOSITIONS AND METHODS FOR CONTROLLING PEST INSECTS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1997-08-14 — — WO disclosed
WO-1997012896-A1 SELECTIVE BINDING COMPLEMENTARY OLIGONUCLEOTIDES EPOCH PHARMACEUTICALS, INC. (US) 1997-04-10 — — WO disclosed
WO-1996040711-A1 CROSS-LINKING OLIGONUCLEOTIDES MICROPROBE CORPORATION (US) 1996-12-19 — — WO disclosed
EP-0661979-A4 CROSS-LINKING OLIGONUCLEOTIDES FOR ENZYME-MEDIATED TRIPLE STRAND FORMATION. MICROPROBE CORP (US) 1995-09-13 — — EP disclosed
EP-0661979-A1 CROSS-LINKING OLIGONUCLEOTIDES FOR ENZYME-MEDIATED TRIPLE STRAND FORMATION MICROPROBE CORPORATION (US) 1995-07-12 — — EP disclosed
WO-1993003736-A1 CROSS-LINKING OLIGONUCLEOTIDES FOR ENZYME-MEDIATED TRIPLE STRAND FORMATION MICROPROBE CORPORATION (US) 1993-03-04 — — WO disclosed
WO-1990003370-A1 DERIVATIVES OF PYRAZOLO[3,4-d]PYRIMIDINE MICROPROBE CORPORATION (US) 1990-04-05 — — WO disclosed
Send feedback